Graniarc 1mg Injection
Marketer
Arco Lifesciences
Salt Composition
Granisetron (1mg)
Overview Graniarc 1mg Injection
Oncaspar 1mg Injection is an antiemetic medication frequently used to manage nausea and vomiting resulting from surgery, cancer chemotherapy, or radiation therapy. Oncaspar 1mg Injection does not alleviate other adverse effects of cancer treatments. Administration is strictly under medical supervision, following the physician's instructions. Continued injections are crucial until medically discontinued; subsequent oral medication may be prescribed. Common side effects include injection site discomfort, headache, constipation, diarrhea, and fatigue. These usually subside upon cessation; however, persistent or bothersome symptoms should be reported to your physician, who can offer mitigating strategies. Prior to use, inform your doctor of any pre-existing heart or liver conditions, or gastrointestinal obstructions. Disclosure of all other medications, including those for epilepsy, cardiac issues, cancer, and depression, is vital due to potential interactions. Pregnant or breastfeeding individuals should consult their healthcare provider.
Primary Ingredients of Graniarc 1mg Injection
No text provided to rephrase.
Uses of Graniarc 1mg Injection
Chemotherapy-induced emesis
Major Benefits of Graniarc 1mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Graniarc 1mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Graniarc 1mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
How Graniarc 1mg Injection works:
Graniarc 1mg injection, an antiemetic, counteracts nausea and vomiting. This is achieved by inhibiting serotonin, a neurotransmitter in the brain that triggers these side effects, often associated with chemotherapy or post-surgical recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Graniarc 1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Graniarc, 1mg dose, is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent harm to the fetus; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The administration of Graniarc 1mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Graniarc 1mg Injection.
KidneySAFE IF PRESCRIBED
Graniarc 1mg Injection appears safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Graniarc 1mg Injection in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Graniarc 1mg Injection :
Should you forget a dose of Graniarc 1mg Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Graniarc 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Good Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | 5-HT3 receptor blockers |
3,018 People bought this recently